- Home
- AXSM vs ACLS Comparison
AXSM vs ACLS Comparison
Compare AXSM & ACLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- ACLS
- Stock Information
- Founded
- AXSM 2012
- ACLS 1995
- Country
- AXSM United States
- ACLS United States
- Employees
- AXSM N/A
- ACLS N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- ACLS Industrial Machinery/Components
- Sector
- AXSM Health Care
- ACLS Technology
- Exchange
- AXSM Nasdaq
- ACLS Nasdaq
- Market Cap
- AXSM 4.0B
- ACLS 3.6B
- IPO Year
- AXSM 2015
- ACLS 2000
- Fundamental
- Price
- AXSM $92.69
- ACLS $97.63
- Analyst Decision
- AXSM Strong Buy
- ACLS Strong Buy
- Analyst Count
- AXSM 14
- ACLS 6
- Target Price
- AXSM $124.57
- ACLS $169.80
- AVG Volume (30 Days)
- AXSM 416.4K
- ACLS 486.1K
- Earning Date
- AXSM 11-04-2024
- ACLS 10-30-2024
- Dividend Yield
- AXSM N/A
- ACLS N/A
- EPS Growth
- AXSM N/A
- ACLS 16.96
- EPS
- AXSM N/A
- ACLS 7.27
- Revenue
- AXSM $291,489,000.00
- ACLS $1,111,497,000.00
- Revenue This Year
- AXSM $42.50
- ACLS N/A
- Revenue Next Year
- AXSM $69.28
- ACLS $13.09
- P/E Ratio
- AXSM N/A
- ACLS $13.44
- Revenue Growth
- AXSM 59.73
- ACLS 8.63
- 52 Week Low
- AXSM $55.02
- ACLS $93.77
- 52 Week High
- AXSM $98.40
- ACLS $183.13
- Technical
- Relative Strength Index (RSI)
- AXSM 61.23
- ACLS 34.39
- Support Level
- AXSM $91.52
- ACLS $95.91
- Resistance Level
- AXSM $96.56
- ACLS $102.05
- Average True Range (ATR)
- AXSM 2.83
- ACLS 4.36
- MACD
- AXSM 0.36
- ACLS -0.78
- Stochastic Oscillator
- AXSM 59.91
- ACLS 9.36
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provide aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services and customer training. Geographically, the group has a business presence in North America, Asia Pacific and Europe, of which key revenue is derived from the Asia Pacific.